English – Page 1556 – TechStock²

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. shares are in focus this weekend after the company unveiled a major capital-return move that instantly reshaped the near‑term narrative around the stock: a fresh $500 million share repurchase authorization, anchored by a $300 million accelerated share repurchase (ASR) funded with new term-loan borrowings. SEC+1 Below is a detailed look at what’s new on Dec. 14, 2025, what Wall Street forecasts currently imply for upside/downside, and the operational and balance‑sheet factors investors are watching heading into the next earnings cycle. CCC stock today: price, range, and ticker clarity (CCC vs. “CCCS”) Because many headlines and

14 December 2025

Nasdaq·NASDAQ:CCC

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise designed to bolster funding for its autoimmune pipeline—while its controlling shareholder, Roivant Sciences, stepped in as the largest buyer. As of the most recent market close ahead of Sunday, December 14, 2025, IMVT shares were around $26.42, up about 6.6% on the day, following heightened volatility and elevated trading activity during the week. Below is what changed, why it matters for investors tracking Immunovant stock, and how Wall Street-style consensus forecasts currently frame upside vs. risk. What’s driving Immunovant stock

14 December 2025

Biotechnology·NASDAQ:IMVT

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also

14 December 2025

Biotechnology·Stock Market

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon (NASDAQ: LULU) stock is back in the spotlight after a Q3 earnings beat, updated fiscal 2025 guidance, a $1.0B buyback authorization increase, a CEO succession announcement, and confirmation it will be removed from the Nasdaq-100. Here’s what investors are watching as of December 14, 2025. lululemon athletica inc. stock (NASDAQ: LULU) has become one of the most talked-about retail names heading into the final stretch of 2025. The story is no longer just about athleisure demand—it’s about a leadership reset, a turnaround effort in the Americas, and index-related catalysts that could influence trading flows before year-end. Because December 14,

14 December 2025

Earnings Reports·Stock Market

EverCommerce (EVCM) Stock News, Analyst Forecasts, and Key Catalysts as of Dec. 14, 2025

Updated: December 14, 2025 EverCommerce Inc. (NASDAQ: EVCM) is back on many investors’ radar after a sharp rebound in December that pushed the stock near its 52‑week high—despite Wall Street remaining split on the company’s near‑term upside. As of December 14, 2025 (a Sunday, when U.S. markets are closed), EVCM last traded at $12.08 after Friday’s session (December 12), a move that capped a notable two‑week surge. StockAnalysis At the same time, the latest “instant alert” coverage dated December 14, 2025 highlights a “Hold” consensus from analysts, continued insider selling activity, and a wide dispersion in price targets—signals that the

14 December 2025

NASDAQ:EVCM

Rivian Stock (RIVN) News, Forecasts and Analysis on Dec. 14, 2025: Autonomy & AI Day, Analyst Upgrades, and What Investors Should Watch Next

Rivian Automotive, Inc. (NASDAQ: RIVN) is ending the week at the center of one of the EV market’s biggest storylines: a sharp stock swing tied to its first Autonomy & AI Day, new in-house self-driving silicon, and a push toward subscription software revenue. As of Sunday, December 14, 2025 (with U.S. markets closed for the weekend), Rivian shares last closed Friday, Dec. 12 at about $18.42, up roughly 12% on the day after a volatile two-session reaction to the company’s autonomy announcements. MarketBeat+2StockAnalysis+2 Below is a detailed, publication-ready breakdown of today’s Rivian stock news, the latest Wall Street forecasts, and

14 December 2025

Electric Vehicles·NASDAQ:RIVN·Stock Market

Clear Secure (YOU) Stock News on Dec. 14, 2025: CMS Medicare.gov Deal, JPMorgan Upgrade, Insider-Sale Filing, and Updated Price Targets

As of Sunday, December 14, 2025, Clear Secure, Inc. (NYSE: YOU) is one of the most talked-about mid-cap “digital identity” names after a sharp rally that pushed the stock to fresh multi-year highs in the last trading session. The move has been fueled by a major U.S. government-related healthcare contract, a bullish JPMorgan analyst upgrade, and renewed debate about whether Clear is transitioning from a travel-adjacent membership business into a broader, reusable identity platform for highly regulated industries. Clear Secure, Inc. Below is a complete, publication-ready rundown of the latest Clear Secure stock news, forecasts, and analyses available as of

14 December 2025

NYSE:YOU·Stock Market

Polestar Stock (PSNY) News on Dec. 14, 2025: Reverse Split Aftermath, Nasdaq Compliance Push, and the Latest Forecasts

Updated: Sunday, December 14, 2025Polestar Automotive Holding UK PLC’s U.S.-listed stock (Nasdaq: PSNY) is drawing fresh attention this weekend after a 1-for-30 reverse split–style ADS ratio change took effect earlier this week, reshaping the share count and headline price but not the company’s underlying challenges: cash burn, tariffs, and a race to stabilize margins while scaling deliveries. Business Wire+2NASDAQ Trader+2 Key takeaways for Polestar investors today What happened to Polestar stock this week Because U.S. markets are closed on Sunday, December 14, the latest “as-of” snapshot reflects Friday’s trading (Dec. 12) and the volatile sessions that followed the corporate action

14 December 2025

NASDAQ:PSNY·Stock Market

Greater Victoria Tourism Won’t Chase FIFA World Cup 2026 “Overflow Dollars,” Destination CEO Says — Victoria, BC News (Dec. 14, 2025)

VICTORIA, B.C. — December 14, 2025 — With Vancouver accelerating preparations for the FIFA World Cup 2026, tourism leaders in Greater Victoria are taking a notably cautious stance: don’t expect a spending windfall on Vancouver Island just because the world will be watching matches across the Salish Sea. A report published by the Victoria Times Colonist says Destination Greater Victoria—the region’s destination marketing organization—“won’t be chasing FIFA overflow dollars.” The organization’s CEO, Paul Nursey, told the newspaper that Vancouver’s role as a World Cup host city is unlikely to yield significant benefits on the Island, signaling a strategy focused on

14 December 2025

Stock Market

Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next

Updated: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) Pfizer Inc. (NYSE: PFE) is ending the week in a familiar spot—trading in the mid‑$20s—while investors weigh a high dividend payout against a fast-moving set of catalysts: new oncology data from the Seagen portfolio, a fresh attempt at an oral obesity drug, ongoing cost-cutting, and a looming shift in the U.S. COVID vaccine policy backdrop. Reuters+3StockAnalysis+3Reuters+3 Below is a detailed roundup of the most important Pfizer stock headlines, forecasts, and analyst takes available as of Dec. 14, 2025, plus what to watch next heading into Pfizer’s scheduled 2026

14 December 2025

NYSE:PFE·Pharmaceuticals·Stock Market

Oracle Stock (ORCL) News Today: AI Spending Shock, OpenAI Data Center Debate, and Wall Street Forecasts (Dec. 14, 2025)

Oracle stock (NYSE: ORCL) has turned volatile after earnings, a $15B AI capex step-up, and OpenAI-linked data center headlines. Here’s the latest news, analyst forecasts, and what investors are watching on Dec. 14, 2025. Dateline: Sunday, December 14, 2025 Oracle Corporation stock is ending the week at the center of a market-wide debate: how quickly “AI infrastructure” spending turns into durable profits—and how much balance-sheet risk investors should accept while waiting. As of the latest available trading update (markets are closed Sunday), Oracle (NYSE: ORCL) is around $189.97, down about $9.06 (~4.6%) from the prior close, following heavy volume and

14 December 2025

Artificial Intelligence·NYSE:ORCL·Stock Market

Fermi Inc. (FRMI) Stock News Today: Shares Sink After $150M Project Matador Funding Deal Ends — Forecasts, Analyst Targets, and What’s Next (Dec. 14, 2025)

Fermi Inc. (NASDAQ: FRMI) stock plunged after a prospective tenant terminated a $150M construction funding agreement tied to Project Matador. Here’s the latest news, forecasts, and analyst outlook as of Dec. 14, 2025. Published/Updated: Sunday, December 14, 2025 (markets closed; prices reflect the latest trading session) Key takeaways What happened to Fermi Inc. stock — and why it matters now Fermi Inc. (also branded as Fermi America; NASDAQ & LSE: FRMI) is facing its first major public-market stress test just months after its October debut: a prospective anchor tenant backed away from a construction funding arrangement linked to Project Matador,

14 December 2025

Financial Forecasts·LSE:FRMI·NASDAQ:FRMI

Previous 1 … 1,554 1,555 1,556 1,557 1,558 … 2,715 Next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026

Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026

Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026

IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026

Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.

Stock Market Today